american diabetes association pancreatitis glp-1 receptor agonist history Glucagon-like peptide-1 agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study 367. GLP-1 Agonists: Clinical Implementation

NICE does not recommend supplements for incretin enhancement in type 2 diabetes management

doi:10.1016/j.cell.2016.05.023 (5) Yang D, et al

PMID: 24373234

Brazils Resolution 2314 green-lights online prescribing, while Drogasils 24-hour cold-chain delivery addresses pen-temperature constraints

References Mller, T

Tobacco Use Disorder Outcomes Wang, Volkow, and colleagues also conducted a study of 222,942 individuals with tobacco use disorder and type 2 diabetes, with findings showing individuals prescribed semaglutide showed a 32% lower risk of tobacco-related healthcare visits and were less likely to need smoking cessation medications or counseling during the 12-month follow-up period, with the most notable effects appearing within the first 30 days (Wang et al., 2024c)